UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1540-1550

2016

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus–Associated, Clinical N2 Oropharyngeal Cancer

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (3), p.512-522

2016

Volltextzugriff (PDF)

Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer

Annals of surgical oncology, 2019-11, Vol.26 (12), p.3807-3808

2019

Volltextzugriff (PDF)

Practice-Changing Findings

Oncology (Williston Park, N.Y.), 2015-07, Vol.29 (7), p.502-504

Fidler, Mary Jo

2015

Volltextzugriff (PDF)

Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial

Journal of thoracic oncology, 2023-09, Vol.18 (9), p.1209-1221

2023

Volltextzugriff (PDF)

Treatment of advanced squamous cell carcinoma of the lung: a review

Translational lung cancer research, 2015-10, Vol.4 (5), p.524-532

2015

Volltextzugriff (PDF)

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107423-107423, Article 107423

2023

Volltextzugriff (PDF)

Impact of Routine Surveillance Imaging on Recurrence in Sinonasal Malignancies

Anticancer research, 2022-11, Vol.42 (11), p.5449-5455

2022

Volltextzugriff (PDF)

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Clinical cancer research, 2008-04, Vol.14 (7), p.2088-2094

2008

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer

Journal of clinical oncology, 2015-01, Vol.33 (2), p.189-194

2015

Volltextzugriff (PDF)

Prevalence and Predictors of Neoadjuvant Therapy for Stage IIIA Non-Small Cell Lung Cancer in the National Cancer Database: Importance of Socioeconomic Status and Treating Institution

International journal of radiation oncology, biology, physics, 2014-06, Vol.89 (2), p.303-312

2014

Volltextzugriff (PDF)

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

BMC cancer, 2018-03, Vol.18 (1), p.310-310, Article 310

2018

Volltextzugriff (PDF)

Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis

International journal of radiation oncology, biology, physics, 2015-06, Vol.92 (2), p.307-316

2015

Volltextzugriff (PDF)

Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients

Cancers, 2019-10, Vol.11 (11), p.1619

2019

Volltextzugriff (PDF)

Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer

American journal of clinical oncology, 2015-12, Vol.38 (6), p.605-609

2015

Volltextzugriff (PDF)

Weight Gain in Advanced Non–Small-Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy Is Associated With Superior Survival

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.985-991

2011

Volltextzugriff (PDF)

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy

Cancers, 2021-03, Vol.13 (6), p.1426

2021

Volltextzugriff (PDF)

Utility of Insulin-like Growth Factor Receptor-1 Expression in Gefitinib-Treated Patients with Non-small Cell Lung Cancer

Anticancer research, 2012-05, Vol.32 (5), p.1705-1710

2012

Volltextzugriff (PDF)

Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls

Therapeutic advances in medical oncology, 2012-03, Vol.4 (2), p.51-60

2012

Volltextzugriff (PDF)

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Cancers, 2022-05, Vol.14 (10), p.2355

2022

Volltextzugriff (PDF)

Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients

Journal of thoracic oncology, 2011-06, Vol.6 (6), p.1079-1086

2011

Volltextzugriff (PDF)

Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2011-02, Vol.71 (2), p.186-190

2011

Volltextzugriff (PDF)

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

JTO clinical and research reports, 2022-08, Vol.3 (8), p.100335-100335, Article 100335

2022

Volltextzugriff (PDF)

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1393-1399

2018

Volltextzugriff (PDF)

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-01, Vol.393 (10167), p.156-167

2019

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(28)
Male
(18)
Aged
(17)
Female
(17)
Middle Aged
(14)
Carcinoma, Non-Small-Cell Lung - Pathology
(13)
Lung Neoplasms - Pathology
(13)
Lung Neoplasms - Drug Therapy
(12)
Treatment Outcome
(12)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(11)
Respiratory System
(11)
Chemotherapy
(10)
Neoplasm Staging
(10)
Hematology, Oncology And Palliative Medicine
(9)
Lung Cancer
(9)
Patients
(9)
Tumors
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus–Associated, Clinical N2 Oropharyngeal Cancer

Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer

Practice-Changing Findings

Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial

Treatment of advanced squamous cell carcinoma of the lung: a review

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Impact of Routine Surveillance Imaging on Recurrence in Sinonasal Malignancies

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer

Prevalence and Predictors of Neoadjuvant Therapy for Stage IIIA Non-Small Cell Lung Cancer in the National Cancer Database: Importance of Socioeconomic Status and Treating Institution

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis

Theoretical and Practical Implications of Treating Cachexia in Advanced Lung Cancer Patients

Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer

Weight Gain in Advanced Non–Small-Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy Is Associated With Superior Survival

Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy

Utility of Insulin-like Growth Factor Receptor-1 Expression in Gefitinib-Treated Patients with Non-small Cell Lung Cancer

Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls

Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients

Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Aktive Filter

Suchergebnisse filtern